Status:
COMPLETED
Electronic Triggers: Messaging After A1C EHR Alert
Lead Sponsor:
NYU Langone Health
Conditions:
Hemoglobins
Diagnostic Tests
Eligibility:
All Genders
18-100 years
Brief Summary
Studying subjects with HbA1C tests \>10 and no follow-up test within 6 months and appointments scheduled in the next 60 days from data run date. Subjects who receive intervention message may be more l...
Eligibility Criteria
Inclusion
- MyChart active patients with HbA1C tests \>10 and no follow-up test within 6 months and no appointments scheduled in the next 60 days from data run date
Exclusion
- Patients with a scheduled appointment within 60 days from time algorithm is run; hospital encounters; non English or Spanish patients as indicated by primary language in Epic
Key Trial Info
Start Date :
July 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 28 2024
Estimated Enrollment :
2403 Patients enrolled
Trial Details
Trial ID
NCT04869319
Start Date
July 13 2020
End Date
March 28 2024
Last Update
April 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016